Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

111213141516171819

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

21st Nov 2023 11:52

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024. Read More

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

14th Nov 2023 17:04

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook. Read More

GSK hails momelotinib opinion from European Medicines Agency committee

13th Nov 2023 09:47

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia. Read More

UK dividends calendar - next 7 days

9th Nov 2023 15:50

Read More

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

8th Nov 2023 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

2nd Nov 2023 10:14

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday: Read More

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

1st Nov 2023 16:52

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US. Read More

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

1st Nov 2023 08:51

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue. Read More

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

1st Nov 2023 08:50

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings. Read More

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

1st Nov 2023 07:40

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision. Read More

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

30th Oct 2023 09:01

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial. Read More

Unilever has lost market confidence and that must change - Barclays

27th Oct 2023 17:29

(Alliance News) - Unilever PLC will need to work hard to restore investor confidence, analysts at Barclays said Friday, though the investment bank believes it would be unfair to have wanted more "fireworks" from the consumer goods firm's new boss. Read More

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

26th Oct 2023 09:19

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria. Read More

UK earnings, trading statements calendar - next 7 days

25th Oct 2023 16:01

Read More

GSK says RSV jab shows promising response in adults aged 50 to 59

25th Oct 2023 09:35

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59. Read More

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

16th Oct 2023 08:09

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer. Read More

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

16th Oct 2023 07:44

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere. Read More

GSK moves to reduce more Zantac "noise" with latest settlement

11th Oct 2023 15:19

(Alliance News) - GSK PLC on Wednesday outlined another Zantac lawsuit settlement, in a move which may aid the pharmaceutical firm removing an "overhang" on its shares. Read More

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

11th Oct 2023 09:17

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

11th Oct 2023 08:51

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank. Read More

111213141516171819
FTSE 100 Latest
Value8,275.66
Change0.00